リパーゼの世界市場 2023年～2030年

概要

世界のリパーゼ市場は、2022年に7億2,912万米ドルに達し、2023-2030年の予測期間中にCAGR 6.53%で成長し、2030年には1兆2,094億1,000万米ドルに達すると予測されています。

健康とウェルネスに対する意識の高まりが、特定の食事性リパーゼ製品に対する需要を牽引しています。リパーゼは低脂肪・低コレステロール食品の製造に使用されます。より健康的な食品を求める消費者が増えており、この動向はリパーゼ市場にプラスの影響を与え続けると予想されます。クリーンラベルや植物由来の食品を求める動きがリパーゼ市場に影響を及ぼしており、メーカー各社はこうした動向に沿った酵素を求めるようになっています。

欧州では、天然成分を使用したクリーンラベル製品に対する需要が急増しています。この動向が、飲食品製造におけるクリーンラベル用酵素としてのリパーゼの利用を促進しています。製造業者は消費者の嗜好に応えるため、非遺伝子組換え生物（non-GMO）やその他の天然由来のリパーゼを求めており、市場が拡大しています。

例えば、DSMは2022年11月8日、原料の性能を最大限に引き出すことを目的とした4つの革新的ソリューションを発表しました。これらの革新的ソリューションの一つであるPanamore XtenseはFiEで発表されました。このラベルフレンドリーなリパーゼは、一般的に使用されている乳化剤DATEMの持続可能な代替品として機能します。パン生地の安定性を高め、ボリュームと形状を最適化することで、パン製造業者に大きなメリットを提供しています。

力学

加工食品の需要拡大

加工食品の消費量の増加は、食品加工の様々な段階におけるリパーゼのような酵素の必要性を刺激しています。リパーゼは脂肪を脂肪酸とグリセロールに分解する役割を果たし、食品製造に欠かせないものとなっています。リパーゼは、食品企業が加工食品の風味を高めるのに役立っています。これにより、味が改善されたスナック菓子や調理済み食品の製造が可能になり、消費者にとってより魅力的なものとなっています。

リパーゼは、賞味期限を延長した食品の開発に貢献しています。脂肪を分解することで腐敗を抑え、加工食品の日持ちを向上させ、製造業者と消費者の双方にとっての重大な関心事に対処しています。食品業界では多様な加工食品の開拓が急増しており、市場の成長を牽引しています。

健康志向の高まり

健康志向の消費者は、より健康的な食品を積極的に求めています。この動向は、低脂肪・低カロリー食品の製造におけるリパーゼの需要を促進し、より良い栄養と体重管理を重視する食生活の嗜好に合致しています。リパーゼ酵素は、味を損なうことなく加工食品の脂肪分を減らすために使用されます。健康志向の高い人々は脂肪分の少ない食品を好み、これが市場の成長を促進する要因となっています。

Pancreatic Cancer Action Networkによると、米国食品医薬品局（FDA）は2022年7月5日、スナック菓子摂取時には10,000～20,000単位のリパーゼを、食事時には20,000～40,000単位のリパーゼを摂取することを推奨しています。患者は、1日4回の食事を想定し、1回の食事で体重1kgあたり2,500単位を超えないというガイドラインを守らなければならないです。

高い製造コスト

リパーゼの製造工程における高い製造コストは、同市場で事業を展開する企業の利益率の低下を招いています。このような収益性の限界は、研究開発、マーケティング、事業拡大のためのリソースを制約し、市場の成長を妨げています。製造コストの高さは、リパーゼベースの製品価格の上昇につながることが多く、市場の成長を抑制しています。

高い製造コストの負担は、リパーゼ市場で事業を展開する中小企業にとって特に課題となっています。これらの企業は競争力のある価格設定を維持することが困難であり、市場成長の可能性を制限しています。高い生産コストは、リパーゼ市場への投資を検討している新規参入企業や新興企業にとって障壁となっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 加工食品への需要の高まり
    • 健康志向の高まり
  • 抑制要因
    • 高い生産コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• ロシア・ウクライナ戦争の影響分析
• DMIの見解

第6章 COVID-19分析

第7章 供給源別

• 微生物
• 動物
• 植物

第8章 形態別

• 液体
• 粉末

第9章 用途別

• 乳製品
• ベーカリー・菓子類
• 動物飼料
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • ロシア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Koninklijke DSM N.V
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Novozymes A/S
• Clerici-Sacco Group
• Renco New Zealand
• Enzyme Development Corporation
• Chr. Hansen Holdings A/S
• Amano Enzymes Inc.
• Associated British Foods PLC
• International Flavors & Fragrances Inc.
• Advanced Enzyme Tech

第13章 付録

Overview

Global Lipase Market reached US$ 729.12 million in 2022 and is expected to reach US$ 1209.41 billion by 2030, growing with a CAGR of 6.53% during the forecast period 2023-2030.

Growing awareness of health and wellness is driving the demand for specific dietary lipase products. Lipases are used in the production of low-fat and low-cholesterol food items. As more consumers seek healthier food choices, this trend is expected to continue influencing the lipase market positively. The clean-label and plant-based food movements are influencing the lipase market, prompting manufacturers to seek enzymes that align with these trends.

Europe is experiencing a surge in demand for clean-label products with natural ingredients. This trend is propelling the utilization of lipases as clean-label enzymes in food and beverage manufacturing. Manufacturers are seeking lipases from non-genetically modified organisms (non-GMO) and other natural sources to meet consumer preferences, expanding the market.

For instance, on November 8, 2022, DSM introduced four innovative solutions aimed at maximizing the performance of raw materials. One of these innovations, Panamore Xtense, was launched at FiE. This label-friendly lipase serves as a sustainable substitute for the commonly used emulsifier DATEM. It offers significant advantages to bread producers by enhancing dough stability and optimizing volume and shape.

Dynamics

Growing Demand for Processed Food

The rising consumption of processed foods is stimulating the need for enzymes like lipase in various stages of food processing. Lipase plays a role in breaking down fats into fatty acids and glycerol, making it indispensable in food manufacturing. Lipase helps food companies enhance the flavor profiles of processed foods. This is leading to the production of snacks and ready-to-eat meals with improved taste, making them more appealing to consumers.

Lipase is contributing to the development of food products with extended shelf life. By breaking down fats, it helps reduce rancidity and improves the longevity of processed food items, addressing a critical concern for both manufacturers and consumers. The food industry is witnessing a surge in the development of diverse processed food products, driving market growth.

Rising Health-Conscious Consumers

Health-conscious consumers are actively seeking out healthier food options. This trend drives the demand for lipase in the production of low-fat and low-calorie food products, aligning with dietary preferences are focusing on better nutrition and weight management. Lipase enzymes are used to reduce the fat content of processed foods without compromising taste. Health-conscious individuals prefer food items with lower fat content, which are factors driving market growth.

According to the Pancreatic Cancer Action Network, on July 5, 2022, the United States Food and Drug Administration (FDA) recommends that individuals begin with a dosage of 10,000 - 20,000 lipase units when consuming snacks and 20,000 - 40,000 lipase units with meals. Patients must adhere to the guideline of not surpassing 2,500 lipase units per kilogram of body weight per meal, assuming a total of four meals per day.

High Production Costs

High production costs in the lipase manufacturing process are leading to reduced profit margins for companies operating in the market. This limited profitability is hindering market growth, as it is constraining resources available for research and development, marketing, and expansion. High production costs often translate into higher prices for lipase-based products, restraining market growth.

The burden of high production costs is particularly challenging for small and medium-sized enterprises (SMEs) operating in the lipase market. These companies are facing difficulties in maintaining competitive pricing, which limits their market growth potential. High production costs are creating barriers for new entrants and startups looking to invest in the lipase market.

Segment Analysis

The global lipase market is segmented based on source, form, application, and region.

Growing Availability, Cost-Effectiveness, and Versatility of Microbial Lipase

The microbial segment held the largest share of the global lipase market. Microbial lipases are derived from microorganisms like bacteria and fungi. It is produced on a large scale, and this widespread availability ensures a stable supply for the market. Microbial lipases are a cost-effective choice for many industries. Their efficient production costs make them an attractive option for various applications.

Microbial lipases display versatility in their catalytic activities, making them suitable for a wide range of applications. This adaptability allows them to serve multiple sectors, such as food and biofuels. Manufacturers and researchers are focusing on enhancing the properties of microbial lipases to meet specific industrial needs. These tailored solutions cater to the diverse requirements of different applications.

Geographical Penetration

Robust Industrial Presence, Diverse Applications in Europe

Europe held the dominant position in the global lipase market. Europe has a strong, well-established food sector in countries such as Germany, France, and Italy, which is contributing significantly to the growth of the lipase market in the region. Europe is maintaining stringent quality and safety standards for the production and application of lipases in various sectors. This commitment to quality and compliance is enhancing the trust of consumers and industries in lipase products.

Lipase enzymes find applications in a wide range of sectors, from the food and pharmaceutical industries to biotechnology. The diversity of applications is allowing Europe to cater to a broad customer base. European companies are continually introducing innovative lipase products tailored to specific industry needs. This product innovation is helping them maintain a strong foothold in the market.

For instance, on May 29, 2020, Biocatalysts Ltd, specialists in enzymes, introduced its latest enzyme, Lipomod 767P. This non-genetically modified microbial lipase preparation is well-suited for both the hydrolysis and esterification of oils and fats. Its wide-ranging pH compatibility allows for use across various substrate types. Lipomod 767P offers the capability to selectively hydrolyze triglycerides, releasing free fatty acids.

COVID-19 Impact Analysis:

The global lipase market faced supply chain disruptions due to lockdowns, restrictions, and transportation challenges, which have affected the timely availability of lipase products in the market. Lipase has applications in various end-user industries, including food, pharmaceuticals, and research. The disruptions in these sectors negatively affected the overall market as businesses scaled back production and research activities.

However, the lipase market experienced growth in the pharmaceutical sector as lipase enzymes played a role in potential treatments or vaccines for COVID-19. This led to increased research and development activities in the pharmaceutical market segment. The pandemic accelerated the adoption of e-commerce and home cooking. As a result, there was increased demand for lipase in consumer-friendly formats for baking and cooking, which benefited the market.

Russia-Ukraine War Impact Analysis

The lipase market has relied on a steady supply of raw materials. The geopolitical tension between Russia and Ukraine led to uncertainties in the sourcing of essential raw materials, which negatively impacted production. The lipase market experienced supply chain disruptions as the conflict disrupted transportation routes and logistics networks. This hampered the timely delivery of lipase products to various regions.

The conflict prompted greater emphasis on sustainability and self-sufficiency in various industries. This shift towards sustainability has driven innovation and growth in the lipase market as consumers and industries have sought more sustainable products. In response to the geopolitical tensions, players in the lipase market explored diversifying their supply sources to mitigate risks associated with dependency on specific regions.

By Source

• Microbial
• Animal
• Plant

By Form

• Liquid
• Powder

By Application

• Dairy
• Bakery and Confectionery
• Animal Feed
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• On August 31, 2023, Alcresta Therapeutics, Inc., a prominent company specializing in the development and commercialization of innovative enzyme-based products, announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the extended use of RELiZORB in children aged 2 to under 5 years. RELiZORB is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase.
• On February 25, 2020, Researchers from the University of Portsmouth, in collaboration with an international team, created an enzyme derived from agricultural waste. This enzyme, produced from a by-product of mustard seeds, has the potential to become a valuable additive in laundry detergents. The aim is to develop an economical, naturally sourced alternative to lipase, the second most widely produced enzyme on the market.
• On December 18, 2023, Zomedica Corp. introduced three new assays - Canine Pancreatic Lipase (cPL), Cobalamin (B12), and Folate - for the TRUFORMA In-Clinic Biosensor Testing Platform.

Competitive Landscape

The major global players in the lipase market include: Koninklijke DSM N.V., Novozymes A/S, Clerici-Sacco Group, Renco New Zealand, Enzyme Development Corporation, Chr. Hansen Holdings A/S, Amano Enzymes Inc., Associated British Foods PLC, International Flavors & Fragrances Inc., and Advanced Enzyme Tech.

Why Purchase the Report?

• To visualize the global lipase market segmentation based on source, form, application, and region, as well as understand critical commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous lipase market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of critical products of all the major players.

The global lipase market report would provide approximately 61 tables, 57 figures, and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Source
• 3.2. Snippet by Form
• 3.3. Snippet by Application
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing Demand for Processed Food
    • 4.1.1.2. Rising Health-Conscious Consumers
  • 4.1.2. Restraints
    • 4.1.2.1. High Production Costs
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Source

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 7.1.2. Market Attractiveness Index, By Source
• 7.2. Microbial*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Animal
• 7.4. Plant

8. By Form

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 8.1.2. Market Attractiveness Index, By Form
• 8.2. Liquid*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Powder

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Dairy*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Bakery and Confectionery
• 9.4. Animal Feed
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Russia
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Koninklijke DSM N.V*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Novozymes A/S
• 12.3. Clerici-Sacco Group
• 12.4. Renco New Zealand
• 12.5. Enzyme Development Corporation
• 12.6. Chr. Hansen Holdings A/S
• 12.7. Amano Enzymes Inc.
• 12.8. Associated British Foods PLC
• 12.9. International Flavors & Fragrances Inc.
• 12.10. Advanced Enzyme Tech

LIST NOT EXHAUSTIVE.

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us